MCHr1 antagonist 2 is primarily utilized in the field of neuroscience and pharmacology for its role in modulating the melanin-concentrating hormone receptor 1 (MCHr1). This compound is of significant interest in research focused on understanding and treating conditions related to appetite regulation and energy balance. It has been explored as a potential therapeutic agent for obesity due to its ability to suppress appetite and reduce food intake. Additionally, MCHr1 antagonist 2 is studied for its potential effects on mood disorders, such as anxiety and depression, as the MCH system is implicated in emotional regulation. Its application extends to preclinical studies aimed at developing novel treatments for metabolic and psychiatric disorders.